Nomura Holdings
VIR icon

Nomura Holdings’s Vir Biotechnology VIR Stock Holding History

Nomura Holdings’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$413K Buy
46,100
+32,100
+229% +$256K ﹤0.01% 1419
2025
Q4 		$84.4K Sell
14,000
-26,000
-65% -$155K ﹤0.01% 1849
2025
Q3 		$228K Hold
40,000
– – ﹤0.01% 1756
2025
Q2 		$202K Hold
40,000
– – ﹤0.01% 1302
2025
Q1 		$259K Buy
+40,000
New +$356K ﹤0.01% 1633

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Nomura Holdings's VIR Position: Q1 2026 in Review

Nomura Holdings opened a new position in Vir Biotechnology (VIR) in Q1 2026: 50,040 shares worth $448K. The stake represents ﹤0.01% of the portfolio and ranks #1395 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in VIR as recently as Q3 2025.

Nomura Holdings first reported a position in VIR in Q2 2025 and has held it in 3 quarters since. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Nomura Holdings held 50,040 shares of Vir Biotechnology worth $448K as of Q1 2026.
  • Vir Biotechnology was a new Nomura Holdings position in Q1 2026.
  • Vir Biotechnology made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1395 holding.
  • Nomura Holdings first reported a position in Vir Biotechnology in Q2 2025 and has held it in 3 quarters since.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.